Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Bionano Genomics, Inc. (BNGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress"
05/09/2023 8-K Quarterly results
Docs: "Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress"
03/09/2023 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Full Year 2022 Results and Provides Revenue Outlook for 2023"
08/04/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022"
11/04/2021 8-K Quarterly results
Docs: "Bionano Genomics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Progress",
"Q3 Webcast and Call November 4, 2021 2 Legal Disclaimer This"
08/04/2021 8-K Quarterly results
Docs: "Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress",
"ADDED EXPERIENCED TALENT TO MANAGEMENT TEAM NEW GLOBAL REGIONS"
03/23/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Opinion of Cooley LLP",
"Bionano Genomics Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/13/2020 8-K Quarterly results
06/18/2020 8-K Quarterly results
Docs: "Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update Company to host conference call today, Thursday, June 18, at 4:30 pm ET SAN DIEGO, June 18, 2020 - Bionano Genomics, Inc. , a life sciences instrumentation company that develops and markets Saphyr ® , a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported its financial results for the first quarter ended March 31, 2020 and provided a business update. Recent Business Highlights"
03/05/2020 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update Conference Call and Webcast scheduled for today, Thursday, March 5 at 4:30 pm ET SAN DIEGO, March 5, 2020 - Bionano Genomics, Inc. , a life sciences instrumentation company that develops and markets Saphyr ® , a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported its financial results for the fourth quarter and year ended December 31, 2019 and provided a business update. Recent Business Highlights"
11/07/2019 8-K Quarterly results
Docs: "Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update Conference Call and Webcast scheduled for today, Thursday, November 7 at 4:30 pm ET SAN DIEGO, November 7, 2019 - Bionano Genomics, Inc. , a life sciences instrumentation company that develops and markets Saphyr ® , a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported its financial results for the third quarter and nine-months ended September 30, 2019 and provided a business update. Recent Business Highlights"
08/08/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "Bionano Genomics Reports First Quarter 2019 Financial Results and Provides Business Update Conference Call and Webcast scheduled for today, May 9, at 4:30 pm ET SAN DIEGO, May 9, 2019 - Bionano Genomics, Inc. , a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported financial results for the first quarter ended March 31, 2019 and provided a business update."
03/14/2019 8-K Quarterly results
Docs: "Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy